Home - Products - Others - Other Targets - Platelet Factor 4 (58-70), human

Platelet Factor 4 (58-70), human

CAS No. 82989-21-7

Platelet Factor 4 (58-70), human ( )

Catalog No. M30366 CAS No. 82989-21-7

Platelet Factor 4 (58-70), human is a polypeptide based on the 58-70 amino acid sequence of Platelet Factor 4 (pf-4) residues.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 186 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    Platelet Factor 4 (58-70), human
  • Note
    Research use only, not for human use.
  • Brief Description
    Platelet Factor 4 (58-70), human is a polypeptide based on the 58-70 amino acid sequence of Platelet Factor 4 (pf-4) residues.
  • Description
    Platelet Factor 4 (58-70), human is a polypeptide based on the 58-70 amino acid sequence of Platelet Factor 4 (pf-4) residues.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82989-21-7
  • Formula Weight
    1573
  • Molecular Formula
    C76H133N17O18
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Jouan V, et al. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood. 1999 Aug 1;94(3):984-93.
molnova catalog
related products
  • Papain

    Papain is a cysteine protease of the peptidase C1 family. Papain is used in food, pharmaceutical, textile, and cosmetic industries.

  • 9,11-Dehydro-beta-bo...

    9,11-Dehydro-β-boswellic acid has urease inhibitory activity. 9,11-Dehydro-beta-boswellic acid inhibiting the key enzyme of leukotriene biosynthesis, 5-lipoxygenase (5-LO).

  • SynuClean-D

    SynuClean-D is an α-synuclein aggregation inhibitor preventing fibril propagation, disrupting mature amyloid fibrils, and abolishing the degeneration of dopaminergic neurons in an animal model of Parkinson’s disease.